How does the severe critical illness driven by COVID19 encode its long-term effects?
Study code
NBR88
Lead researcher
Dr Alasdair Jubb
Study type
Samples and data
Institution or company
Cambridge University Hospital NHS Foundation Trust
Researcher type
Academic
Speciality area
Infection, COVID
Summary
This study aims to compare changes in a specific type of white blood cell between patients who have had COVID. The comparison will be between patients who received treatment in an Intensive Care Unit (ICU) and those whose treatment was managed on a hospital ward. The aim is to understand the long-term complications seen in patients who required ICU treatments.
Participation: For this study, blood samples and data from 44 COVID-19 BioResource volunteers were provided.
Organisation: This study is organised by Dr Alasdair Jubb from the Department of Medicine, University of Cambridge